{"updated":"2025-01-21T14:49:43.020908+00:00","metadata":{"_oai":{"id":"oai:ipsj.ixsq.nii.ac.jp:00092669","sets":["1164:5352:7133:7203"]},"path":["7203"],"owner":"11","recid":"92669","title":["Distinction of Type 2 diabetes using PCA, miRNA as features"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-06-20"},"_buckets":{"deposit":"6e55defd-4591-4a23-a727-06137c75fada"},"_deposit":{"id":"92669","pid":{"type":"depid","value":"92669","revision_id":0},"owners":[11],"status":"published","created_by":11},"item_title":"Distinction of Type 2 diabetes using PCA, miRNA as features","author_link":["0","0"],"item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Distinction of Type 2 diabetes using PCA, miRNA as features"},{"subitem_title":"Distinction of Type 2 diabetes using PCA, miRNA as features","subitem_title_language":"en"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"合同企画セッション：バイオデータマイニング","subitem_subject_scheme":"Other"}]},"item_type_id":"4","publish_date":"2013-06-20","item_4_text_3":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"Department of Physics, Chuo University"},{"subitem_text_value":"Department of Physics, Chuo University"}]},"item_4_text_4":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_value":"Department of Physics, Chuo University","subitem_text_language":"en"},{"subitem_text_value":"Department of Physics, Chuo University","subitem_text_language":"en"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_publisher":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"情報処理学会","subitem_publisher_language":"ja"}]},"publish_status":"0","weko_shared_id":-1,"item_file_price":{"attribute_name":"Billing file","attribute_type":"file","attribute_value_mlt":[{"url":{"url":"https://ipsj.ixsq.nii.ac.jp/record/92669/files/IPSJ-BIO13034027.pdf"},"date":[{"dateType":"Available","dateValue":"2015-06-20"}],"format":"application/pdf","billing":["billing_file"],"filename":"IPSJ-BIO13034027.pdf","filesize":[{"value":"621.3 kB"}],"mimetype":"application/pdf","priceinfo":[{"tax":["include_tax"],"price":"660","billingrole":"5"},{"tax":["include_tax"],"price":"330","billingrole":"6"},{"tax":["include_tax"],"price":"0","billingrole":"41"},{"tax":["include_tax"],"price":"0","billingrole":"44"}],"accessrole":"open_date","version_id":"2167809e-df2d-43af-8560-49572b2c4f97","displaytype":"detail","licensetype":"license_note","license_note":"Copyright (c) 2013 by the Information Processing Society of Japan"}]},"item_4_creator_5":{"attribute_name":"著者名","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shodai, Katsukawa"},{"creatorName":"Y-H.Taguchi"}],"nameIdentifiers":[{}]}]},"item_4_creator_6":{"attribute_name":"著者名(英)","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shodai, Katsukawa","creatorNameLang":"en"},{"creatorName":"Y-H., Taguchi","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_4_source_id_9":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA12055912","subitem_source_identifier_type":"NCID"}]},"item_4_textarea_12":{"attribute_name":"Notice","attribute_value_mlt":[{"subitem_textarea_value":"SIG Technical Reports are nonrefereed and hence may later appear in any journals, conferences, symposia, etc."}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourceuri":"http://purl.org/coar/resource_type/c_18gh","resourcetype":"technical report"}]},"item_4_description_7":{"attribute_name":"論文抄録","attribute_value_mlt":[{"subitem_description":"Type II diabetes (T2D) was a critical symptom also related to other diseases including cancers. Thus, suppression of T2D is important. In this paper, we investigated microRNAs as candidates of drug targets and biomarkers. A recently proposed principal component analysis based linear discriminant analysis allows us to specify numerous miRNAs differently expressed between type II diabetes patients and healthy control. Type II diabetes, Impaired Fasting Glucose patients, and normal control are successfully discriminated by blood miRNAs.","subitem_description_type":"Other"}]},"item_4_description_8":{"attribute_name":"論文抄録(英)","attribute_value_mlt":[{"subitem_description":"Type II diabetes (T2D) was a critical symptom also related to other diseases including cancers. Thus, suppression of T2D is important. In this paper, we investigated microRNAs as candidates of drug targets and biomarkers. A recently proposed principal component analysis based linear discriminant analysis allows us to specify numerous miRNAs differently expressed between type II diabetes patients and healthy control. Type II diabetes, Impaired Fasting Glucose patients, and normal control are successfully discriminated by blood miRNAs.","subitem_description_type":"Other"}]},"item_4_biblio_info_10":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicPageEnd":"2","bibliographic_titles":[{"bibliographic_title":"研究報告バイオ情報学（BIO）"}],"bibliographicPageStart":"1","bibliographicIssueDates":{"bibliographicIssueDate":"2013-06-20","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"27","bibliographicVolumeNumber":"2013-BIO-34"}]},"relation_version_is_last":true,"weko_creator_id":"11"},"created":"2025-01-18T23:41:30.209840+00:00","id":92669,"links":{}}